中文

翰宇药业 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-29
ItemAmountY/Y
Revenue¥0.30B-3.5%
Gross profit¥0.19B
Operating income¥0.14B
Net income¥0.13B+83.5%
Gross margin64.9%Net margin 42.6%
Revenue Q/Q+5.6%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.11B35.1%
R&D¥0.03B10.3%
SG&A¥0.04B14.9%
Tax & other¥0.01B3.3%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

高盟新材海伦哲聚光科技舒泰神*ST天喻理邦仪器欣旺达行云科技森远股份*ST亿通*ST易录佳讯飞鸿

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies